Amphotericin B-related nephrotoxicity has an economic impact on hospitals and health systems - Reply

被引：2

作者：

Harbarth, S

Samore, MH ^{[1
]}

机构：

[1] Univ Utah, Sch Med, Dept Internal Med, Div Infect Dis, Salt Lake City, UT 84132 USA

[2] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2003年 / 37卷 / 10期

关键词：

D O I：

10.1086/379128

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1396 / 1397

页数：2

共 5 条

[1] Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients [J].

Cagnoni, PJ ;

Walsh, TJ ;

Prendergast, MM ;

Bodensteiner, D ;

Hiemenz, S ;

Greenberg, RN ;

Arndt, CAS ;

Schuster, M ;

Seibel, N ;

Yeldandi, V ;

Tong, KB .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (12) :2476-2483

[2]

GREENBERG RN, 2002, J MED ECON, V5, P109

[3] The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy [J].

Harbarth, S ;

Pestotnik, SL ;

Lloyd, JF ;

Burke, JP ;

Samore, MH .

AMERICAN JOURNAL OF MEDICINE, 2001, 111 (07) :528-534

[4] Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity [J].

Harbarth, S ;

Burke, JP ;

Lloyd, JF ;

Evans, RS ;

Pestotnik, SL ;

Samore, MH .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (12) :E120-E127

[5]

Prendergrast MM, 2003, CLIN INFECT DIS, V37, P1396, DOI 10.1086/379134

← 1 →